There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
The next decade of drug development will depend on better ways of storing, using, and analyzing data, says CPhI advisor Bikash Chatterjee, president and chief science officer of Pharmatech Associates. But each of the following must be optimized: volume, variety, velocity, veracity, and value.
The agency published a guideline for the implementation of ICH Q3D.
Visual inspection of parenteral vials is the first step in a root cause investigation.
The Chinese facility was cited for data integrity violations.
New technology introduced in 2016 aids innovation growth for pharmaceutical manufacturing.
This paper describes a unique Prep-rP-HPLC technique that uses a C-18/C-8 derivatized silica coated with a hydrophobic quaternary ammonium salt or quaternary phosphonium salt that acts as an additional/surrogate stationary phase (AsP/ssP).
Conventional limit-setting techniques are not health-based and can make risk assessment more difficult.
Stability testing programs should provide drug owners the information needed to establish the proper handling, shipping, and shelf-life recommendations for drug products.
Multiple methods are required for detecting and removing protein impurities.
NIST’s monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.
The agency recommends suspending drugs developed with bioequivalence studies performed at Semler Research Centre Private Ltd, Bangalore, India.
The Nexera-i MT from Shimadzu incorporates two flow lines, which allow for both UHPLC and HPLC analysis.
FDA issued a warning letter to the Worthing, UK facility for cross contamination and microbial contamination cGMP violations.
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
The draft guidance addresses control of elemental impurities in harmonization with implementation of ICH Q3D guideline.
Integrating quality and compliance with technology transfer and careful project management are key in starting up a facility and launching a biologic drug.
The authors' directed isotopic synthesis is one example of how molecular isotopic engineering can be used to predetermine the discrete isotopic ranges of biopharmaceutical products.
A vessel for the Hanson Research Vision G2 series of dissolution testers is designed to provide more consistent vessel-to-vessel dissolution test results.
The assay, co-developed by Grifols and Hologic, will be used to test blood donations in the United States.
Do you have acceptable control of your instruments and analytical procedures?
Process analytical technology paved the way for continuous manufacturing.
SPECTRO XEPOS spectrometers handle rapid screening elemental analysis and support product quality control at-line for the manufacture of pharmaceuticals.
